FDA applicant

Exelint International, Co.

Los Angeles, CA7 decisions2000–20250 recalls

FDA records 7 decisions for Exelint International, Co. (Los Angeles, CA) from 2000 to 2025: 7 510(k) clearances. Most are in product codes FMI (Needle, Hypodermic, Single Lumen) and FPA (Set, Administration, Intravascular). Its devices cite 3 predicates, 0 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Exelint International, Co.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2007high 1 (2010) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Exelint International, Co. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Exelint International, Co.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Exelint”

FDA records each applicant name separately; these may or may not be the same firm.

Exelint Intl. Co. 12

Exelint International, Co.

Which product codes does it file in?

Whose devices does it build on?

What has FDA decided for it lately?

Other applicant names beginning “Exelint”